Transarterial Chemoembolization of Renal Cell Carcinoma: A Prospective Controlled Trial

Amar Karalli(Karolinska University Hospital), Ove Gustafsson(The University of Melbourne), Torkel B. Brismar(Karolinska University Hospital), Bela Bozoki(Karolinska University Hospital), Ramin Ghaffarpour(Karolinska University Hospital), Rimma Axelsson(Karolinska University Hospital), Lars Lundell(Karolinska Institutet)

Journal of Vascular and Interventional Radiology

September 22, 2017

10.1016/j.jvir.2017.08.001

Cited by 25

Related Papers

A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.

|Gastroenterology|2004|526

Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update

|Radiology Artificial Intelligence|2024|406

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

|Gastroenterology|2012|378

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial

|JHEP Reports|2021|220

Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients

|Clinical Nutrition|2015|179